Description

Description

Xiga-Met XR 10/500mg Tablet is an extended-release fixed-dose combination medicine designed for adults with type 2 diabetes mellitus who need the full standard dose of Dapagliflozin paired with a lower, gradually released dose of Metformin. Unlike combinations that use the reduced 5mg Dapagliflozin strength, this formulation delivers the complete 10mg dose, offering the strongest available kidney-based glucose excretion effect from this SGLT2 inhibitor while keeping the Metformin component at a lower, extended-release level. This particular pairing is often chosen for patients who need a stronger SGLT2 inhibitor effect but are earlier in their Metformin titration, or those who tolerate Metformin better at lower doses while still requiring the full Dapagliflozin benefit. The pack contains 14 tablets, generally supporting a two-week course based on once-daily dosing, and this medicine should only be started or adjusted under close medical supervision.

Ingredients

Each Xiga-Met XR 10/500mg Tablet contains Dapagliflozin 10mg together with Metformin Hydrochloride 500mg in extended-release form. The full-strength Dapagliflozin dose works by inhibiting the SGLT2 protein in the kidneys, maximizing the reduction in glucose reabsorption and promoting greater excretion of sugar through urine, while the extended-release Metformin component is embedded within a controlled-release polymer matrix, typically built using hydroxypropyl methylcellulose, that regulates its gradual dissolution and absorption. Additional inactive ingredients commonly include microcrystalline cellulose, magnesium stearate, colloidal silicon dioxide, and a film coating that supports the tablet’s structure and appearance.

Dosage Form

This medicine is manufactured as a film-coated, extended-release oral tablet, formulated with a controlled-release matrix that allows the Metformin component to be absorbed gradually while delivering the full Dapagliflozin dose immediately. The tablets are supplied in blister strips that protect them from moisture and light, helping preserve the release mechanism’s integrity until the expiry date printed on the packaging.

Uses

Xiga-Met XR 10/500mg Tablet is used to manage blood sugar levels in adults with type 2 diabetes mellitus who require the maximum standard Dapagliflozin dose combined with a lower, steadily released Metformin dose. The full-strength Dapagliflozin component provides the strongest kidney-based glucose excretion effect available in this combination, working independently of insulin, while the extended-release Metformin component provides a gradual reduction in liver glucose production and improves insulin sensitivity over time. This tablet is often prescribed for patients who need more intensive SGLT2 inhibitor support but are still in the earlier stages of Metformin dose titration, or those who experience better digestive tolerability at lower Metformin levels. As with other combination therapies, it is generally used alongside dietary management, regular exercise, and consistent monitoring to support long-term blood sugar control.

How to Use

Xiga-Met XR 10/500mg Tablet should be taken exactly as directed by the prescribing doctor, typically once daily in the morning or with a meal, depending on specific instructions. The tablet must always be swallowed whole with a glass of water and should never be crushed, broken, or chewed, as this could disrupt the extended-release mechanism governing the Metformin component. Patients should maintain good hydration throughout treatment, as the full-strength Dapagliflozin component increases urine output more noticeably than lower SGLT2 inhibitor doses. Patients may occasionally notice a tablet-shaped residue in their stool, which is simply the depleted shell of the extended-release matrix and is considered a normal, harmless occurrence. Doses should not be doubled to make up for a missed one; instead, the missed dose should be taken as soon as remembered unless the next dose is close.

Side Effects

At the full 10mg Dapagliflozin strength, effects related to increased urinary glucose excretion may be more pronounced for some patients, including more frequent urination, genital yeast infections, and urinary tract infections. Some patients may also experience mild dizziness, increased thirst, or symptoms of fluid loss, particularly if hydration is not adequately maintained. Effects linked to the Metformin component at this lower dose are generally mild and may include nausea, occasional diarrhea, or a metallic taste, often easing as the body adjusts. In rare but serious cases, symptoms of euglycemic diabetic ketoacidosis (nausea, vomiting, abdominal pain, unusual fatigue) linked to the full Dapagliflozin dose, or lactic acidosis linked to Metformin, may occur and require urgent medical attention. Any severe, persistent, or unusual symptoms should be reported to a doctor promptly.

Pregnancy & Breastfeeding

Xiga-Met XR 10/500mg Tablet is generally not recommended during pregnancy, as both the SGLT2 inhibitor and biguanide components are typically discontinued once pregnancy is confirmed, since diabetes management during pregnancy usually follows a different treatment protocol. Women who are pregnant, planning a pregnancy, or currently breastfeeding should inform their doctor before starting or continuing this medicine so that safer alternatives can be considered. Breastfeeding mothers should also seek medical guidance, as the safety of this combination during lactation has not been clearly established.

Storage Instructions

Store Xiga-Met XR 10/500mg Tablets in a cool, dry place away from direct sunlight, excess heat, and humidity, ideally at a temperature below 30°C. Keep the tablets in their original blister packaging until they are ready to be used, to help protect the extended-release coating, and store them securely out of the reach and sight of children and pets. Avoid storing this medicine in bathrooms or other damp areas, and never allow the tablets to freeze. Always check the expiry date before use, and dispose of any expired or unused tablets responsibly through an appropriate medicine disposal program rather than household waste or drains.

FAQS

Q1. Why does this combination use the full 10mg Dapagliflozin dose with a lower Metformin dose?
This pairing is often chosen for patients who need stronger SGLT2 inhibitor support but are earlier in their Metformin titration or tolerate it better at lower doses.

Q2. Is the risk of urinary infections higher with this strength?
Since it contains the full 10mg Dapagliflozin dose, some patients may notice a slightly higher likelihood of genital or urinary tract infections compared to the 5mg combinations.

Q3. Can the Metformin dose be increased later while keeping the same Dapagliflozin strength?
Yes, doctors may adjust the Metformin component over time based on tolerance and blood sugar response, while keeping the Dapagliflozin dose consistent if it is working well.

Q4. Is hydration especially important with this combination?
Yes, since it contains the full Dapagliflozin dose, maintaining good fluid intake is particularly important to offset increased urine output.

Q5. Can this tablet be crushed if swallowing whole is difficult?
No, it should always be swallowed whole, as crushing can disrupt the Metformin extended-release mechanism and alter how the medicine is absorbed.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.